Ask Stago (english version)

Stago
  • 0.0 (0)
  • LIFE SCIENCES
  • UPDATED DAILY
Ask Stago (english version) Podcast

Ask Stago: EXPERT ANSWERS TO YOUR EXPERT QUESTIONS Ask Stago is the podcast for Hemostasis laboratory professionals. In less than 10 minutes, Lisa Gannon and Anne-Cécile Ortega host special guests to provide “expert answers to your expert questions”. Stay abreast of hot topics in Hemostasis through Ask Stago! Contribute to the discussion by sending your questions to ask@stago.com  Follow us on LinkedIn and Twitter -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

  1. S5E3 - What are microvesicles, their importance in coagulation and how to analyze them?

    4 JUN

    S5E3 - What are microvesicles, their importance in coagulation and how to analyze them?

    Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in coagulation. In today’s episode, Karine Carrière  will explain further what are microvesicles, their importance in coagulation and how to analyze them.  Literature sources: [Tesselaar et al.], [Lacroix et al.] [Faille et al.] [Mullier et al.] Vallier et al.] . [Nieuwland et al.] Kim HK, Song KS, Park YS, Kang YH, Lw YJ, Lw KR, et al. Elevated levels of circulating platelet microparticles, VEGF, 11-6 and FiANTES in patients Wlth gastrlc cancer. possible mle of a metastasis predlotor. Eur J Cancer 2003;39(2):184-91. Helley D, Banu E, Bouziane A, Banu A, Scotte F, Fiher AM, et al. Platelet microparticles: a potential predictive factor of survival in hormone-reac pmstate cancer patients treated with docetaxel-based chemotherapy. Eur Urnl2009;56(3):479-84. Zwicker JI, Liebman HA, Neuberg D, Lecmix R, Bauer KA, Furie BC, et ai. Tmr-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15 (22): 68630-40   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    11 min
  2. S5E2 - Living with a rare blood clotting disorder, Hemophilia C: an interview with Joseph Bautista

    7 MAY

    S5E2 - Living with a rare blood clotting disorder, Hemophilia C: an interview with Joseph Bautista

    Welcome to Ask Stago, the Podcast dedicated to provide expert answers to your expert questions in coagulation. This month we meet Joseph Bautista, is a 37 year old US man living with a rare clotting disorder, a Factor XI deficiency otherwise known as Hemophilia C. His journey so far has not been an easy one but by educating himself and advocating for the best care he is living a full and healthy life working as a data architect in the IT sector. Its an inspiring and reassuring story for anyone facing a rare bleeding disorder diagnosis & proves the importance of patient empowerment.   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    14 min
  3. S5E1 - What is new in ISO 15189:2022?

    2 APR

    S5E1 - What is new in ISO 15189:2022?

    Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in coagulation. In today’s episode, our guest Evelyne Escarmant will help us to understand what is behind the recent update of ISO 15189 and what it means for us as manufacturers and indeed the clinical laboratory Literature sources:  ISO 15189; Medical laboratories – Requirements for quality and competence   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    12 min
  4. S4E4 - Limit of detection (LoD) and limit of quantitation (LoQ): what are we talking about?

    23/05/2023

    S4E4 - Limit of detection (LoD) and limit of quantitation (LoQ): what are we talking about?

    Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in coagulation. In today’s episode, our guest Florence Crépet will help us to understand what is behind the wording “limit of blank”, “limit of detection” and “limit of quantification”, and what it means for the clinical laboratory Literature sources: Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S49-52. CLSI. Evaluation of Detection Capability for Clinical Laboratory Measurement  Procedures; Approved  Guideline—Second  Edition. CLSI  document EP17-A2. Wayne,  PA: Clinical and Laboratory  Standards Institute; 2012. CLSI Evaluation of Detection Capability Implementation Guide. CLSI Document EP17-Ed2-IG. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    15 min
  5. S4E3 - Women at work and Women in Science

    07/03/2023

    S4E3 - Women at work and Women in Science

    Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in coagulation. In this episode, to coincide with International Womens Day (March 8th), we are focusing on Gender equality in the workforce, why this is good for business and good for society overall. We meet with Eva Ohlsson Desormonts, Group HR Director for Stago and Amandine Serret International Business Support and Communications Director for Stago as well as an Executive Coach. Literature sources: Women in the Workpace 2022, McKinsey & Company whitepaper Challenges facing early career women in thrombosis and hemostasis—meeting the needs of the next generation, Guest Editorial, J Thromb Haemost. 2022;20:2453-5455   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    10 min
  6. S4E2 - Women’s health series (part 2): Anti-phospholipid syndrome awareness

    07/02/2023

    S4E2 - Women’s health series (part 2): Anti-phospholipid syndrome awareness

    Welcome to Ask Stago, the Podcast dedicated to provide expert answers to your expert questions in coagulation. In today’s episode, we are delighted to speak to April Matera. April experienced a stroke at the age of 39 and from there began her journey towards an anti-phospholipid syndrome diagnosis. Unfortunately it took 7 different visits to 7 different doctors to get her there. She tells us here about her APS road and how it has impacted her life and her dream to have a family.   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    14 min
  7. S4E1 - Women’s health series (part 1): Women’s health and coagulation

    03/01/2023

    S4E1 - Women’s health series (part 1): Women’s health and coagulation

    Welcome to Ask Stago, the Podcast dedicated to provide expert answers to your expert questions in coagulation. In this series of our new season we will be covering Womens’ health and looking at the broader implications of coagulation and then speaking to a Lupus patient advocate on the impact this disease has had for her personally. To start off, in today episode, we are delighted to speak to our Clinical Development Director, Dr Francois Depasse about the broader connection between Womens’ Health and coagulation and then a more in depth look at APS. Links to related podcasts: S1E13 - Lupus anticoagulant diagnosis work-up https://www.podcastics.com/podcast/episode/13-the-lupus-anticoagulant-diagnosis-work-up-54015/ S3E7 - Hemostasis results interpretation along pregnancy https://www.podcastics.com/podcast/episode/s3e7-hemostasis-results-interpretation-along-pregnancy-134753/ Literature sources: https://www.cdc.gov/ncbddd/blooddisorders/women/facts.html Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306 Devreese KMJ, Ortel TL, Pengo V, de Laat B; Subcommittee on Lupus anticoagulant/Antiphospholipid antibodies. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16: 809-813 CLSI Laboratory testing for the Lupus anticoagulant - Approved Guideline. CLSI document H60-A. Wayne, PA; 2014. Devreese, KMJ, de Groot, PG, de Laat, B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020; 18: 2828– 2839. https://doi.org/10.1111/jth.15047    Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    9 min
  8. S3E12 - Fibrinolysis: the often missed key player of hemostasis

    06/12/2022

    S3E12 - Fibrinolysis: the often missed key player of hemostasis

    Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in coagulation. In today’s episode, our guest Professor Romaric Lacroix will explain us how fibrinolysis is important to the whole hemostasis process and how the sample fibrinolytic activity needs to be evaluated and sometimes monitored. Link to previous podcasts: S1E15 – Disseminated Intravascular Coagulation (DIC) and fibrin related markershttps://www.podcastics.com/podcast/episode/15-disseminated-intravascular-coagulation-dic-and-fibrin-related-markers-54016/   Literature sources: Cointe S, Vallier L, Esnault P, Dacos M, Bonifay A, Macagno N, Harti Souab K, Chareyre C, Judicone C, Frankel D, Robert S, Hraiech S, Alessi MC, Poncelet P, Albanese J, Dignat-George F, Lacroix R. Granulocyte microvesicles with a high plasmin generation capacity promote clot lysis and improve outcome in septic shock. Blood. 2022 Apr 14;139(15):2377-2391. Cointe S, Harti Souab K, Bouriche T, Vallier L, Bonifay A, Judicone C, Robert S, Armand R, Poncelet P, Albanese J, Dignat-George F et Lacroix R. A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance. J Extracell Vesicles 2018; Jul 16;7(1):1494482 Vallier L, Cointe S, Lacroix R, Bonnifay A, Judicone C, Dignat-George F, Hau C. Kwaan. Microparticle and fibrinolysis. Semin Thromb Hemost. 2017 Mar;43(2):129-134   Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

    10 min
See All (55)

About

Ask Stago: EXPERT ANSWERS TO YOUR EXPERT QUESTIONS Ask Stago is the podcast for Hemostasis laboratory professionals. In less than 10 minutes, Lisa Gannon and Anne-Cécile Ortega host special guests to provide “expert answers to your expert questions”. Stay abreast of hot topics in Hemostasis through Ask Stago! Contribute to the discussion by sending your questions to ask@stago.com  Follow us on LinkedIn and Twitter -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

Information

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada